Universal Newborn Screening For Sickle Cell Disease In Mozambique

The overarching goal of this study is to evaluate the feasibility of a new methodology that combines three multi-level implementation strategies to optimize the population-level uptake of essential evidence-based, standard of care treatments for infants with sickle cell disease (SCD) in low-resource settings. The study will be done in Mozambique.

NCT Number	NCT07719972
Lead Sponsor	St. Jude Children's Research Hospital
Conditions	Sickle Cell Disease
Enrollment	6,750 participants
Start Date	2026-08
Primary Completion	2031-08 (estimated)
Study Completion	2031-08 (estimated)
Updated on ClinicalTrials.gov	2026-07-22